5-{4-[2-(5-Ethyl-1-oxido-2-pyridinyl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione(CAS: 145350-09-0)

This compound, CAS 145350-09-0, is subject to various regulatory guidelines such as GHS classification, which mandates the use of specific hazard labels and safety data sheets. For manufacturing and import/export, REACH regulations in the EU require registration and reporting of substances above one tonne per year. FDA/EPA guidelines may apply for pharmaceutical and environmental concerns respectively.

In synthesis, alternatives to this compound include other thiazolidine derivatives with similar functional groups, such as ethyl 5-(4-{[2-(5-ethyl-2-pyridyl)ethoxy]methyl}-1,3-thiazolidin-2-ylidene)hydantoin. Isomers and analogs can also be considered based on specific application requirements and availability.

The market for this compound is expanding in pharmaceutical applications due to its potential as a bioisostere in drug design. Research trends indicate increasing interest in its use as a lead compound for developing anti-inflammatory and antiviral drugs. Market analysis suggests growing demand driven by emerging studies highlighting its biological activity.

Waste containing this compound should be collected and stored in sealed containers to prevent environmental contamination. Proper incineration or professional waste disposal services should be utilized, adhering to local and international environmental regulations. Precautions include ensuring the waste is neutralized or treated appropriately before disposal to minimize the risk of chemical exposure and environmental impact.